Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference16 articles.
1. The economic cost of brain disorders in Europe;Olesen;Eur. J. Neurol.,2012
2. Disease-modifying treatments for progressive multiple sclerosis;Comi;Mult. Scler.,2013
3. A much-needed focus on progression in multiple sclerosis;Thompson;Lancet Neurol.,2015
4. Overcoming barriers in progressive multiple sclerosis research;Coetzee;Lancet Neurol.,2015
5. Foundation–industry relationships – a new business model joint-venture philanthropy in therapy development;Bartek;Curr. Top. Med. Chem.,2014
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The refined Pathways to Cures Research Roadmap for multiple sclerosis cures;Multiple Sclerosis Journal;2024-08-30
2. The role of accounting in the assessment of knowledge production from a multi-stakeholder's perspective;SUSTAIN ACCOUNT MANA;2022
3. Collective health research assessment: developing a tool to measure the impact of multistakeholder research initiatives;Health Research Policy and Systems;2022-05-02
4. Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2022-04
5. The MULTI-ACT model: the path forward for participatory and anticipatory governance in health research and care;Health Research Policy and Systems;2022-02-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3